GoetzKloeckerMD

Clinical Trials

• Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer Start of enrollment: 2005 Feb 01

  Terminated

  Phase 2

• Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer Start of enrollment: 2005 Feb 01

  Terminated

  Phase 1

• Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer Start of enrollment: 2006 Feb 01

  Terminated

  Phase 2

• Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia Start of enrollment: 2007 May 01

  Withdrawn

  Phase 2

• Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer Start of enrollment: 2006 Oct 01

  Completed

  Phase 2

• The Effect of Beta-glucan in Non-Small Cell Lung Cancer Start of enrollment: 2008 Oct 01

  Recruiting

  Not Applicable

• Port Will be Flushed Every 3 Months Instead of Every 4-6 Wks, as Recommended by Port Manufacturer. Start of enrollment: 2009 Mar 01

  Completed

  Phase 2

• STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO) Start of enrollment: 2011 Feb 01

  Withdrawn

  Not Applicable

• Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01

  Terminated

  Phase 2, Phase 3

• An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients. Start of enrollment: 2014 Oct 01

  Withdrawn

  Phase 4

• Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01

  Terminated

  Phase 2

• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03

  Active, not recruiting

  Phase 3

• Join now to see all